A newly approved drug that gives the immune system a boost helped stall the spread of tumors in patients with advanced bladder cancer, researchers reported Sunday. It’s not a slam-dunk, but it’s ...
Bladder cancer is the fourth most common cancer in men and the sixth most common type of the disease overall. But it's a relatively under-recognized cancer, says Dr. Arjun Balar, director of the ...
Fibroblast Growth Factor Receptor 1 Gene Amplification Is Associated With Poor Survival and Cigarette Smoking Dosage in Patients With Resected Squamous Cell Lung Cancer Patients with Karnofsky ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window SAN FRANCISCO -- ...
The FDA today approved the first new treatment for metastatic bladder cancer in nearly 30 years. The drug, called atezolizumab, is a type of immunotherapy treatment designed to boost the body's ...
A new drug that harnesses the immune system to attack tumors is highly effective against advanced bladder cancer, according to the results of an international clinical trial to be presented June 5 at ...
A newly approved immunotherapy from Roche Holding proved effective as an initial treatment for some patients with advanced bladder cancer, according to data presented on Sunday. Results of the ...
CHICAGO — The anti-PD-L1 immunotherapy atezolizumab (Tecentriq, Genentech), which recently made headlines when it was approved for second-line use in bladder cancer, appears to be effective in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback